The missing kiss of life: Transcriptional activity of the metastasis suppressor gene KiSS1 in early breast cancer

Anticancer Research

Volumn 27, Issue 4 B, 2007, Pages 2499-2504

  Kostadima, L ^a   Pentheroudakis, G ^a   Pavlidis, Nicholas ^a  

^a UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

Author keywords

Breast cancer; KiSS1; Metastasis suppressor gene; Survival

Indexed keywords

BIRC5 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HORMONE RECEPTOR; MESSENGER RNA; METASTIN; PROTEIN; PROTEIN BCL 2; PROTEIN P53; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; LOG RANK TEST; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SUPPRESSOR GENE; TUMOR VOLUME;

ADENOCARCINOMA; BREAST NEOPLASMS; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; MIDDLE AGED; NEOPLASM STAGING; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 34547814250     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. American Cancer Society: Cancer statistics 1998. CA Cancer J Clin 48: 1-63, 1998.
2. Chambers AF: The metastatic process: basic research and clinical implications. Oncol Res 11: 161-168, 1999.
3. Yoshida BA, Sokoloff M, Welch DR and Rinker-Schaeffer CW: Metastasis-suppressor genes: a review and perspective on an emerging field. J Natl Cancer Inst 92: 1717-1730, 2000.
4. West A, Vojta PJ, Welch DR and Weissman BE: Chromosome localisation and genomic structure of the KiSS1 metastasis suppressor gene (KISS1). Genomics 54: 145-148, 1998.
5. Nash KT and Welch DR: The KISS1 metastasis suppressor: mechanistic insights and clinical utility. Front Biosci 11: 647-659, 2006.
6. Fountzilas G, Skarlos D, Dafni U, Gogas H, Briasoulis E, Pectasides D, Papadimitriou C, Markopoulos C, Polychronis A, Kalofonos HP, Siafaka V, Kosmidis P, Timotheadou E, Tsavdaridis D, Bafaloukos D, Papakostas P, Razis E, Makrantonakis P, Aravantinos G, Christodoulou C and Dimopoulos AM: Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomised phase III study conducted by HeCOG. Ann Oncol 16: 1762-1771, 2005.
7. Debies MT and Welch DR: Genetic basis of human breast cancer metastasis. J Mamm Gland Biol Neoplasia 6: 441-451, 2002.
8. Muir AI, Chamberlain L, Elsbourbagy NA, Michalovich D, Moore DJ, Calamari A, Szekeres PG, Sarau HM, Chambers JK, Murdock P, Steplewski K, Shabon U, Miller JE, Middleton SE, Darker JG, Larminie CGC, Wilson S, Bergsma DJ, Emson P, Faull R, Philpott KL and Harrison DC: AXOR12: A novel human G-protein coupled receptor, activated by the peptide KiSS-1. J Biol Chem 76: 28969-28975, 2001.
9. Ohtaki T, Shintani Y, Honda S, Matsumoto H, Hori A, Kanehashi K, Terao Y, Kumano S, Takatsu Y, Masuda Y, Ishibashi Y, Watanabe T, Asada M, Yamada T, Suenaga M, Kitada C, Usuki S, Kurokawa T, Onda H, Nishimura O and Fujino M: Metastasis suppressor gene KiSS1 encodes peptide ligand of a G-protein coupled receptor. Nature 11: 613-617, 2001.
10. Kotani M, Detheux M, Vandenbogaerde A, Communi D, Vanderwinden JM, Le Poul E, Brézillon S, Tyldesley R, Suarez-Huerta N, Vandeput F, Blanpain C, Schiffmann SN, Vassart G and Parmentier M: The metastasis-suppressor gene KiSS1 encodes kisspeptins, the natural ligands of the orphan G-protein coupled GPR54. J Biol Chem 76: 34631-34636, 2001.
11. Rouille Y, Duguay SJ, Lund K, Futura M, Gong Q, Lipkind G, Oliva AA, JR, Chan SJ and Steiner DF: Proteolytic processing mechanisms in the biosynthesis of neuroendocrine peptides: the subtilisin-like proprotein convertases. Front Neuroendocrinol 16: 322-361, 1995.
12. Terao Y, Kumano S, Takatsu Y, Hattori M, Nishimura A, Ohtaki T and Shintani Y: Expression of KiSS1, a metastasis-suppressor gene, in trophoblast giant cells of the rat placenta. Biochim Biophys Acta 1678: 102-110, 2004.
13. Lee JH, Miele ME, Hicks DJ, Phillips KK, Trent JM, Weissman BE and Welch DR: KiSS1, a novel human malignant melanoma metastasis-suppressor gene. J Natl Cancer Inst 88: 1731-1737, 1996.
14. Hori A, Honda S, Asada M, Ohtaki T, Oda K, Watanabe T, Shintani Y, Yamada T, Suenaga M, Kitada T, Onda H, Kurokawa T, Nishimura O and Fujino M: Metastin suppresses the motility and growth of CHO cells transfected with its receptor. Biochem Biophys Res Comm 286: 958-963, 2001.
15. Goldberg SF, Harms JF, Quon K and Welch DR: Metastasis-suppressed C8161 melanoma cells arrest in lung but fail to proliferate. Clin Exp Metastasis 17: 601-607, 1999.
16. Lee JH and Welch DR: Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1. Cancer Res 57: 2384-2387, 1997.
17. Sanchez-Carbayo M, Capodieci P and Cordon-Cardo C: Tumour suppressor role of KiSS-1 in bladder cancer: loss of KiSS1 expression is associated with bladder cancer progression and clinical outcome. Am J Pathol 162: 609-617, 2003.
18. Shirashaki F, Takata M, Hatta N and Takehara K: Loss of expression of the metastasis suppressor gene KiSS1 during melanoma progression and its association with LOH of chromosome 6q16.3-q23. Cancer Res 61: 7422-7425, 2001.
19. Ringel MD, Hardy E, Bernet VJ, Burch HB, Schuppert F, Burman KD and Saji M: Metastin receptor is overexpressed in papillary thyroid cancer and activates MAP kinase in thyroid cancer cells. J Clin Endocrin Metab 87: 2399, 2002.
20. Dhar DK, Naora H, Kubota H, Maruyama R, Yoshimura H, Tonomoto Y, Tachibana M, Ono T, Otani H and Nagasue N: Downregulation of KiSS-1 expression is responsible for tumour invasion and worse prognosis in gastric carcinoma. Int J Cancer 111: 868-872, 2004.
21. Jiang T, Zhang SL, Lin B, Meng LR and Gao H: Expression and clinical significance of KISS1 and GPR54 mRNA in endometrial carcinoma. Zhonghua Zhong Liu Za Zhi 27: 229-231, 2005.
22. Stark AM, Tongers K, Mass N, Mehdorn HM and Held-Feindt J: Reduced metastasis-suppressor gene mRNA expression in breast cancer brain metastases. J Cancer Res Clin Oncol 131: 191-198, 2005.
23. Jiang Y, Berk M, Singh LS, Tan H, Yin L, Powell CT and Xu Y: KiSS1 suppresses metastasis in human ovarian cancer via inhibition of protein kinase C alpha. Clin Exp Metastasis 22: 369-376, 2005.
24. Yan CH, Wang H and Boyd DD: KiSS-1 represses 92-kDa type IV collagenase expression by down-regulating NF-kappaB binding to the promoter as a consequence of IkBa-induced block of p65/p50 nuclear translocation. J Biol Chem 276: 1164-1172, 2001.
25. Navenot JM, Wang Z, Chopin M, Fujii N and Peiper SC: Kisspeptin-10- induced signaling of GPR54 negatively regulates chemotactic responses mediated by CXCR4: a potential mechanism for the metastasis suppressor activity of kisspeptins. Cancer Res 65: 10450-10456, 2005.
26. Mitchell DC, Abdelrahim M, Weng J, Stafford LJ, Safe S, Bar-Eli M and Liu M: Regulation of KiSS-1 metastasis suppressor gene expression in breast cancer cells by direct interaction of transcription factors AP2a and SP1. J Biol Chem 281(1): 51-58, 2005.
27. Welch DR, Chen P, Miele ME, McGary CT, Bower JM, Stanbridge EJ and Weissman BE: Microcell-mediated transfer of chromosome 6 into metastatic human C8161 melanoma cells suppresses metastasis but does not inhibit tumorigenicity. Oncogene 9: 255-262, 1994.
28. Pentheroudakis G, Kostadima L, Dova L, Malamou-Mitsi V, Georgiou I, Fountzilas G, Stropp U, Vartholomatos G, Kolaitis N and Pavlidis N: The missing kiss of life: Analysis of mutation and protein expression of the metastasis-suppressor gene KISS1 in early breast cancer. Ann Oncol 17(Suppl 9): ix59(101P), 2006.
29. Martin TA, Watkins G and Jiang WG: KiSS1 expression in human breast cancer. Clin Exp Metastasis 22: 503-511, 2005.